BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21394784)

  • 1. Immediate response to botulinum toxin injections in patients with fixed dystonia.
    Edwards MJ; Bhatia KP; Cordivari C
    Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical therapy and botulinum toxin in dystonia.
    Jankovic J
    Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
    O'Brien CF
    Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laryngeal dystonia].
    Barbosa ER
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):829. PubMed ID: 11593295
    [No Abstract]   [Full Text] [Related]  

  • 9. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A survey about the accessibility to botulinum toxin therapy for dystonia].
    Mezaki T; Hayashi A; Nakase H; Hasegawa K
    No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blepharospasm: treatment with botulinum toxin].
    Barbosa ER; Silva HC; Haddad MS; Bittar MS
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(6):220-3. PubMed ID: 9239894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint hypermobility syndrome: a risk factor for fixed dystonia?
    Kassavetis P; Batla A; Pareés I; Saifee TA; Schrag A; Cordivari C; Bhatia KP; Edwards MJ
    Mov Disord; 2012 Jul; 27(8):1070. PubMed ID: 22532260
    [No Abstract]   [Full Text] [Related]  

  • 14. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin.
    Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G
    Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin: historical perspective and potential new indications.
    Jankovic J; Brin MF
    Muscle Nerve Suppl; 1997; 6():S129-45. PubMed ID: 9826986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
    Gudex CM; Hawthorne MR; Butler AG; Duffey P
    Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic focal dystonia of the foot in a 98-year-old-woman. Treatment with botulin toxin].
    Verlhac B; Dobigny-Roman N; Forette B
    Presse Med; 1996 Dec; 25(40):2042. PubMed ID: 9082380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Repetitive non-instrumental use dystonia].
    Vercueil L
    Rev Neurol (Paris); 2009 Jan; 165(1):92-3; author reply 94. PubMed ID: 19084248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.